北美护理点诊断市场预测至 2028 年 - COVID-19 影响和按产品进行区域分析(血糖监测产品、传染病检测产品、心脏代谢检测产品、妊娠和生育检测产品、凝血检测产品、肿瘤/癌症标志物检测产品) 、胆固醇检测产品、尿液分析检测产品、血液学检测产品和其他 POC 产品)、处方模式(处方检测和 OTC 检测)和最终用户(专业诊断中心、家庭护理、研究实验室等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 178    |    Report Code: TIPRE00023729    |    Category: Life Sciences

North America Point of Care Diagnostics Market

市场介绍

北美是最大的护理诊断市场。该地区包括美国、加拿大和墨西哥。北美市场的增长特点是传染病日益流行、政府对先进诊断试剂盒和仪器的支持以及市场参与者加大研发活动力度。此外,诊断行业的技术进步可能成为北美护理诊断市场的主要增长动力。在美国,医疗保险和医疗补助服务中心 (CMS) 负责指导医疗保险,这是一项针对 65 岁以上成年人和残疾人的联邦计划,并与州政府合作。 CMS 维持医疗补助和儿童健康保险计划 (CHIP),后者是针对各种低收入人群的联邦州计划的集合。医疗保险提供医生服务、住院治疗以及自愿补充计划、处方药的承保。此外,能够在研发方面投入大量资金的顶级创收医疗器械公司的存在支持了市场增长,因为这些公司制造创新的医疗器械。

就 COVID-19 而言,北美特别是美国受到的影响很大。 COVID-19 大流行病的爆发为护理诊断市场的参与者带来了一些有利的前景。北美有相当多的人口感染了冠状病毒。例如,美国是北美地区受影响最严重的国家。电晕对成年人的影响较轻;然而,这对老年人来说却是不利的。老年人感染新冠病毒导致了严重的并发症,并导致该国大量死亡。但在疫情期间,生命科学公司致力于开发治疗危及生命的疾病的新药。此外,对快速检测设备的需求不断增长也在北美护理诊断市场的增长中发挥着重要作用。此外,由于 COVID-19 人口数量的不断增加,对护理点诊断试剂盒的采用产生了积极影响。这种采用正在促进新产品的开发和市场的推出。例如,2020 年 7 月,Eurofins US Clinical Diagnostics 宣布推出聚合 PCR 检测来检测 SARS-CoV-2,这将大大降低客户每次 PCR 检测的成本。此外,2020 年 3 月,雅培 (Abbott) 的用于诊断 COVID-19 的分子护理点测试获得 FDA 批准。该测试能够在五分钟内得出阳性结果,并在不到十五分钟内得出阴性结果。此类产品的推出预计将加速北美即时诊断市场的增长。

市场概况和动态

北美护理点诊断市场预计将从2021年的166.124亿美元增长到2028年的387.0211亿美元;预计 2021 年至 2028 年复合年增长率为 12.8%。举办各种会议和活动,让人们了解设备并概述建立和维护即时测试时应应用的共同关键原则(POCT)服务。这些会议/活动的参与者可以利用这些知识来开发一个引入 POCT 的框架,以满足与其家庭实践相关的特定临床需求。 2019年6月,SELECTBIO举办了Point-of-Care、Biosensors &移动诊断会议。护理点诊断和移动诊断的新兴趋势和主题、用于护理点应用的微流体设备的商业化以及用于护理点传染病诊断和监测的纸基分析设备是主要内容本次会议涵盖的主题。因此,会议和活动数量的激增预计将促进市场增长。

关键细分市场

就以下方面而言:从产品来看,2020年北美即时诊断市场中,血糖监测产品细分市场占据最大份额。从处方模式来看,处方检测细分市场在北美即时诊断市场中占有较大的市场份额。 2020 年。此外,2020 年,专业诊断中心细分市场在基于最终用户的北美护理点诊断市场中占据更大份额。

主要来源和上市公司

u>

准备本北美护理点诊断市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培(Abbott); BD;生物梅里埃公司;生物拉德实验室有限公司;丹纳赫; F. 霍夫曼拉罗什有限公司;强生服务公司;诺瓦生物医学;聚合物技术系统公司(PTS);和西门子股份公司。  

购买报告的理由

  • 了解北美护理点诊断市场格局,并确定最有可能保证强劲回报的细分市场
  • 通过了解不断变化的趋势,在竞争中保持领先地位-北美护理点诊断市场不断变化的竞争格局
  • 通过确定最有前景的可能销售的细分市场,有效规划北美护理点诊断市场的并购和合作交易
  • < li>通过对北美护理点诊断市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得北美各个细分市场 2021-2028 年的市场收入预测地区

北美护理点诊断市场细分

< strong>北美护理点诊断市场 - 按产品

  • 血糖监测产品
  • 传染病检测产品
    • HIV 检测
    • 流感检测
    • 性传播疾病 (STD) 检测
    • 丙型肝炎检测
    • 医疗保健相关感染( HAI) 检测
    • 热带疾病检测
    • 呼吸道感染检测
    • 其他传染病检测
  • 心脏代谢检测产品
  • 妊娠和生育力检测产品
  • 凝血检测产品
  • 肿瘤/癌症标志物检测产品
  • 胆固醇检测产品
  • 尿液分析检测产品
  • 血液学检测产品
  • 其他 POC 产品

北美护理点诊断市场 -

按处方模式

  • 基于处方的测试
  • OTC测试

北美护理点诊断市场 -

最终用户

  • 专业诊断中心
    • 医院
    • 临床实验室
    • 门诊医疗保健
    • 门诊医疗机构
    • li>
  • 家庭护理
  • 研究实验室
  • 其他

北部美国护理点诊断市场 - 按国家/地区

  • 美国
  • 加拿大
  • 墨西哥
  • 北美护理点诊断市场 - 公司简介

    • Abbott
    • BD
    • bioMerieux SA
    • BIO-RAD LABORATORIES INC.
    • 丹纳赫
    • F 。 HOFFMANN-LA ROCHE LTD.
    • Johnson and Johnson Services, Inc.
    • Nova Biomedical
    • Polymer Technology Systems, Inc. (PTS)
    • < li>西门子公司


    North America Point of Care Diagnostics Strategic Insights

    Strategic insights for North America Point of Care Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/north-america-point-of-care-diagnostics-market-strategic-framework.webp
    Get more information on this report

    North America Point of Care Diagnostics Report Scope

    Report Attribute Details
    Market size in 2021 US$ 16,612.40 Million
    Market Size by 2028 US$ 38,702.11 Million
    Global CAGR (2021 - 2028) 12.8%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 产品
    • 血糖监测产品
    • 传染病检测产品
    • 心脏代谢检测产品
    • 妊娠及生育检测产品
    • 凝血检测产品
    • 肿瘤/癌症标志物检测产品
    • 胆固醇检测产品
    • 尿液分析检测产品
    • 血液学检测产品
    • 其他POC产品
    By 处方模式
    • 处方检测
    • OTC检测
    By 最终用户
    • 专业诊断中心
    • 家庭护理
    • 研究实验室
    Regions and Countries Covered 北美
    • 美国
    • 加拿大
    • 墨西哥
    Market leaders and key company profiles
  • Abbott
  • BD
  • bioMerieux SA
  • BIO-RAD LABORATORIES INC.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • Johnson and Johnson Services, Inc.
  • Nova Biomedical
  • Polymer Technology Systems, Inc. (PTS)
  • Siemens AG
  • Get more information on this report

    North America Point of Care Diagnostics Regional Insights

    The regional scope of North America Point of Care Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-point-of-care-diagnostics-market-geography.webp
    Get more information on this report

The List of Companies - North America Point of Care Diagnostics Market

  1. Abbott
  2. BD
  3. bioMerieux SA
  4. BIO-RAD LABORATORIES INC.
  5. Danaher
  6. F. HOFFMANN-LA ROCHE LTD.
  7. Johnson and Johnson Services, Inc.
  8. Nova Biomedical
  9. Polymer Technology Systems, Inc. (PTS)
  10. Siemens AG
Frequently Asked Questions
How big is the North America Point of Care Diagnostics Market?

The North America Point of Care Diagnostics Market is valued at US$ 16,612.40 Million in 2021, it is projected to reach US$ 38,702.11 Million by 2028.

What is the CAGR for North America Point of Care Diagnostics Market by (2021 - 2028)?

As per our report North America Point of Care Diagnostics Market, the market size is valued at US$ 16,612.40 Million in 2021, projecting it to reach US$ 38,702.11 Million by 2028. This translates to a CAGR of approximately 12.8% during the forecast period.

What segments are covered in this report?

The North America Point of Care Diagnostics Market report typically cover these key segments-

  • 产品 (血糖监测产品, 传染病检测产品, 心脏代谢检测产品, 妊娠及生育检测产品, 凝血检测产品, 肿瘤/癌症标志物检测产品, 胆固醇检测产品, 尿液分析检测产品, 血液学检测产品, 其他POC产品)
  • 处方模式 (处方检测, OTC检测)
  • 最终用户 (专业诊断中心, 家庭护理, 研究实验室)
  • What is the historic period, base year, and forecast period taken for North America Point of Care Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Point of Care Diagnostics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in North America Point of Care Diagnostics Market?

    The North America Point of Care Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • BD
  • bioMerieux SA
  • BIO-RAD LABORATORIES INC.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • Johnson and Johnson Services, Inc.
  • Nova Biomedical
  • Polymer Technology Systems, Inc. (PTS)
  • Siemens AG
  • Who should buy this report?

    The North America Point of Care Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Point of Care Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.